Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Review of Meningococcal Group B Vaccines

9 Feb 2010

Abstract excerpt

No broadly effective vaccines are available for prevention of group B meningococcal disease, which accounts for >50% of all cases. The group B capsule is an autoantigen and is not a suitable vaccine target. Outer-membrane vesicle vaccines appear to be safe and effective, but serum bactericidal responses in infants are specific for a porin protein, PorA, which is antigenically variable. To broaden protection,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacterial Infections and Vaccines
Share to Neonatal and Maternal Infections
Share to Pneumonia and Respiratory Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20144017
DOI: 10.1086/648966

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Review of Meningococcal Group B VaccinesPMID 20144017Read ↗

The Development of a Vaccine Against Meningococcus B Using Reverse VaccinologySemantic proximity Read ↗

Meningococcal Outer Membrane Vesicle Vaccines Derived from Mutant Strains Engineered To Express Factor H Binding Proteins from Antigenic Variant Groups 1 and 2Semantic proximity Read ↗

<i>Neisseria meningitidis</i>serogroup B bivalent factor H binding protein vaccineSemantic proximity Read ↗

Strategies for Development of Universal Vaccines Against Meningococcal Serogroup B DiseaseSemantic proximity Read ↗

Identification of Vaccine Candidates Against Serogroup B Meningococcus by Whole-Genome SequencingSemantic proximity Read ↗

Meningococcal serogroup B vaccines: Estimating breadth of coverageSemantic proximity Read ↗

<i>Neisseria meningitidis</i>B vaccines: recent advances and possible immunization policiesSemantic proximity Read ↗

A large portion of meningococcal antigen typing system-negative meningococcal strains from spain is killed by sera from adolescents and infants immunized with 4CMenB.Semantic proximity Read ↗

Quest for a broad-range vaccine against Neisseria meningitidis serogroup B: implications of genetic variations of the surface-exposed proteins.Semantic proximity Read ↗

Characterization of Neisseria meningitidis Isolates That Do Not Express the Virulence Factor and Vaccine Antigen Factor H Binding ProteinSemantic proximity Read ↗

Deletion of major porins from meningococcal outer membrane vesicle vaccines enhances reactivity against heterologous serogroup B Neisseria meningitidis strainsSemantic proximity Read ↗

A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.